MM LAB Software Matches Oncology Patients to Treatments

March 8, 2016

The software allows pathology labs, hospitals, genomic cores and physicians to match patients’ test results to personalized cancer treatments, including clinical trials and experimental drugs.

MolecularMatch, a personalized cancer treatment company launched its MM LAB software, which is available through an online portal. The software allows pathology labs, hospitals, genomic cores and physicians to match patients’ test results to personalized cancer treatments, including clinical trials and experimental drugs, in real-time. After test results are matched to treatments in MM LAB, the options are curated by the client laboratory's staff and included in the reports sent back to physicians and patients. The solution works using molecular science / artificial intelligence based algorithms.

Read the full release.

 

Related Content:

News